AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Develops and markets medicines, focusing on respiratory and cardiovascular treatments.

001540 | KO

Overview

Corporate Details

ISIN(s):
KR7001540004
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동, 과천시

Description

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-03-03 00:00
대표이사변경
Korean 9.8 KB
2022-02-23 00:00
현금ㆍ현물배당결정
Korean 8.4 KB
2022-02-23 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2022-02-23 00:00
주주총회소집결의
Korean 16.8 KB
2022-01-07 00:00
신탁계약해지결과보고서
Korean 16.7 KB
2021-12-24 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 28.0 KB
2021-12-24 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 27.6 KB
2021-12-14 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2021-11-15 00:00
분기보고서 (2021.09)
Korean 1.3 MB
2021-09-24 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 28.4 KB
2021-08-17 00:00
반기보고서 (2021.06)
Korean 1.3 MB
2021-06-24 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 28.5 KB
2021-05-18 00:00
[기재정정]분기보고서 (2021.03)
Korean 1.2 MB
2021-05-17 00:00
분기보고서 (2021.03)
Korean 1.2 MB
2021-05-14 00:00
주식등의대량보유상황보고서(일반)
Korean 96.4 KB

Automate Your Workflow. Get a real-time feed of all AHN-GOOK PHARMACEUTICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AHN-GOOK PHARMACEUTICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AHN-GOOK PHARMACEUTICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Cognition Inc. Logo
A biopharmaceutical company developing treatments for neurodegenerative diseases.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufacturer of critical reagents for the life sciences industry.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
A clinical-stage biotech developing novel treatments for neurodegenerative diseases.
United States of America
ATHE
Altimmune, Inc. Logo
Clinical-stage biopharma developing peptide therapeutics for obesity and liver diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Develops precision medicines for neuropsychiatric conditions using patient biology.
United States of America
ANRO
ALUMIS INC. Logo
Clinical-stage biopharma developing precision medicines for autoimmune diseases.
United States of America
ALMS
Alvotech Holdings S.A Logo
A biotechnology company developing and manufacturing biosimilar medicines worldwide.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage immuno-oncology company developing therapies to combat cancer.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Develops treatments for neurodegenerative diseases and psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Clinical-stage biopharma developing immunotherapies for Alzheimer's disease.
Sweden
ALZ

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.